Today: 9 June 2026
Alien Talk Fades Around Interstellar Comet 3I/ATLAS as New Searches Find No Signals and Images Turn Green
8 January 2026
2 mins read

Alien Talk Fades Around Interstellar Comet 3I/ATLAS as New Searches Find No Signals and Images Turn Green

WASHINGTON, January 7, 2026, 21:00 EST

  • Green Bank Telescope search reported no radio “technosignatures” from interstellar comet 3I/ATLAS
  • New Gemini North image shows a green glow linked to gases boiling off as the comet warmed near the Sun
  • NASA’s Europa Clipper ultraviolet instrument spotted the comet’s tails from deep space; scientists said some features need more work to explain

Astronomers scanning interstellar comet 3I/ATLAS for signs of alien technology came up empty, a result that adds weight to the case that the fast-moving visitor is natural, not a spacecraft.

That matters now because 3I/ATLAS is only the third object ever confirmed to have entered the solar system from interstellar space, and it is already on its way back out. As it recedes, it will dim and slip beyond the reach of many instruments, leaving researchers with a narrowing window.

The scrutiny is also a rehearsal. Astronomers expect future sky surveys to flag more interstellar passers-by, and they want a clearer picture of what “normal” looks like when a comet formed around another star gets briefly warmed by ours.

Researchers tied to the Breakthrough Listen search project used the Green Bank Telescope to look for “technosignatures” — telltale evidence of technology — and found none, Space.com reported. “We all would have been thrilled to find technosignatures coming from 3I/ATLAS, but they’re just not there,” Benjamin Jacobson-Bell of the University of California, Berkeley, told the publication, which said the work was posted as a pre-peer-reviewed paper on arXiv. https://www.space.com/astronomy/asteroids/…

On the ground, the Gemini North telescope in Hawaii captured a newly released image of 3I/ATLAS from Nov. 26, showing the comet with a green hue. Scientists quoted by BBC Sky at Night Magazine said the color comes from light emitted by gases in the coma — the cloud of gas and dust around a comet — including diatomic carbon, which glows at green wavelengths.

A separate set of observations came from far closer in. NASA’s Europa Clipper spacecraft, headed for Jupiter’s moon Europa, used its ultraviolet spectrograph on Nov. 6 to study 3I/ATLAS days after perihelion — its closest pass to the Sun — when the comet was about 203 million km (126 million miles) from the Sun, IFLScience reported. “We’re still scratching our heads about some of the things we’re seeing,” said Kurt Retherford, the instrument’s principal investigator at Southwest Research Institute, after models did not fully account for what the spacecraft saw in the comet’s tails. https://www.iflscience.com/interstellar-co…

Retherford told IFLScience the team was “excited” to see gases streaming from the comet — “hydrogen and oxygen atoms for sure” — and said the European Space Agency’s JUICE mission also observed 3I/ATLAS, with full data from both missions expected later.

3I/ATLAS has drawn intense attention partly because it is rare: the only other confirmed interstellar visitors are 1I/‘Oumuamua, spotted in 2017, and 2I/Borisov, detected in 2019, Space.com said. Unlike typical comets bound to the Sun, it is passing through on a one-time trajectory and will leave the solar system.

But key questions will linger. The Breakthrough Listen study cited by Space.com is not yet peer-reviewed, and Europa Clipper and JUICE teams are still working through their datasets. Ground-based watchers also warn that comet activity can shift in fits and starts as heat works into the interior, raising the chance of late outbursts even as the object grows fainter.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus
Previous Story

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

Citigroup stock slips ahead of Jan. 14 earnings as bank season nears
Next Story

Citigroup stock slips ahead of Jan. 14 earnings as bank season nears

Go toTop